Interventional Management of Stroke (IMS) Study.
Phase of Trial: Phase II
Latest Information Update: 09 Dec 2015
At a glance
- Drugs Alteplase (Primary) ; Alteplase (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Therapeutic Use
- Acronyms IMS
- 18 Jul 2012 Actual end date (May 2007) added as reported by ClinicalTrials.gov.
- 12 May 2009 Additional lead trial centre (National Institute of Neurological Disorders and Stroke) and lead trial investigators (Broderick JP, Tomsick TA) added as reported by ClinicalTrials.gov
- 04 Jun 2007 Status changed from in progress to completed